NMP Acquisition Corp. Rights - For Shares NMPAR 深 滬
交易中 12-24 10:06:33 美东时间
0.2301
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 0.2301
- 總市值 367.49万
- 52周最高 0.3522
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 0.18
- 委 比 -93.55%
- 總股本 1597.08万
- 歷史最高 0.3522
- 量 比 0
- 振 幅 0.00%
- 歷史最低 0.18
- 每 手 1
- 風險率 0.03%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Monopar Announces Abstract Accepted for Oral Presentation at AASLD - The Liver Meeting® 2025
Monopar Therapeutics Inc. announced that its Phase 2 ALXN1840-WD-204 copper balance study abstract has been selected for oral presentation at the AASLD Liver Meeting 2025. The session, titled "Rapidly Improved Cu Balance in Wilson Disease Patients on Tiomolybdate Choline," will take place on November 9, 2025, at 9:00-9:15 am EST. For more details, visit the conference website or www.monopartx.com.
10-15 12:00
Monopar Therapeutics Inc. Announces Pricing of $135 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Monopar Therapeutics Inc. announced the pricing of an underwritten registered offering of 1,034,433 shares of its common stock at $67.67 per share, with pre-funded warrants offered to certain investors. The gross proceeds are expected to be approximately $100 million, with $35 million allocated to purchasing shares from Tactic Pharma, LLC. The company plans to use the remaining net proceeds for general corporate purposes, including research and d...
09-24 03:08
